Medical tourism in Japan for regenerative treatment usually follows eight steps: screening, collecting records, confirming the clinic's filed plan, arranging the guarantor and visa, consent, collection and culture where needed, treatment, and follow-up at home. The step most often skipped is confirming that the clinic has filed a plan for the specific treatment, because Japan's Safety Act requires that filing before a regenerative treatment is provided. The rest of the sequence depends on that answer and on the visa, which must go through a guarantor on the official lists.

Step 1: Screen the condition and the option

Start with a clear question: what condition you want treated, and what kind of cell therapy is being proposed for it. Some options are approved products, some are clinical trials, and some are self-pay treatments under the Safety Act. Those are different routes with different evidence, so the first step is to sort the option into one of them.

Our pre-screening form helps you do that before you spend money on travel. The aim is to avoid two common losses: traveling for a treatment that is not filed in Japan, and arriving without the medical information a clinic needs to judge suitability.

Step 2: Gather and translate medical records

Japanese doctors will want to see your diagnosis, medical history, current medications, allergies and recent test results. Bring the most recent reports, not older ones. Ask the clinic which language the documents should be in before you translate anything, and keep the translation faithful to the original, with diagnosis names, values and units unchanged.

High-angle view of a dense cityscape with illuminated building windows, a red lattice tower, dark hills on the horizon, and a bright orange band of sky above.

For a fuller list, see what medical records to bring to Japan.

Step 3: Confirm the filed plan

This is the central checkpoint. A clinic in Japan that offers regenerative medicine must file a plan for each technique under the Safety Act, after review by a certified committee. The plan names the class of treatment, and a Class I treatment must wait 90 days after filing before it can be provided.

Ask the clinic which technique you would receive, which class it falls under, which committee reviewed it and when the plan was filed. Then send the clinic's name and the treatment description to our advisors, and we will check whether the clinic has filed a provision plan for that treatment and whether the class matches what you were told. A plan that has not been filed for your treatment means the treatment cannot lawfully be provided.

Filing is a legal step, not evidence of effectiveness. Use the answers to decide whether the treatment is lawful to offer, then judge the evidence separately. The how Japan regulates regenerative medicine page explains the system in more detail.

Step 4: Arrange the guarantor and the visa

Treatment in Japan can require a medical stay visa. Under the joint guidance from the Ministry of Foreign Affairs, the Japan Tourism Agency and the Ministry of Economy, Trade and Industry, the visa is issued to a foreign patient or a companion travelling to receive care ordered by a Japanese medical institution. The category covers care that a Japanese medical institution orders, with examples that include medical checkups, dental treatment and recuperation.

A medical stay visa requires a guarantor. The guarantor must be a registered travel agency (list A, registered by the Japan Tourism Agency) or a registered international medical coordinator (list B, registered by the Ministry of Economy, Trade and Industry). Both lists are published by the Ministry of Foreign Affairs. The guarantor and the receiving hospital jointly issue the medical institution's schedule certificate and the guarantor's guarantor letter, which the patient submits with the visa application.

A medical stay visa does not prevent a patient from applying for a short-stay visa for other purposes, so the right visa depends on the trip. Our medical visa guide covers the documents and the guarantor's duties in more detail.

Step 5: Agree the treatment and what you are consenting to

Before any collection or treatment, the clinic should explain the treatment in writing: what it is, what the expected benefit is, what the risks are, what it costs and what alternatives exist. Read the document in full, and ask about anything you do not understand. Keep copies of everything you sign.

Ask the clinic also how it handles adverse events. Under the Enforcement Regulations, a serious suspected event such as a death or a possible death must be reported within 7 days, and a hospitalization, disability or other serious case within 15 days. Knowing the reporting path helps you understand what will happen if a reaction occurs.

Step 6: Collection and culture, if the treatment uses your cells

Some treatments use the patient's own tissue, such as fat or blood. Collection is a procedure in its own right. Culture then takes time, so the schedule can require more than one trip. Ask the clinic for a written timeline that shows how many visits are needed and where each step happens.

If the cells are cultured by an outside manufacturer, ask the clinic who the manufacturer is and what quality testing is done. The filed plan should describe the manufacturing and quality control arrangements.

Step 7: Treatment

Treatment follows the filed plan and the consent you signed. Before leaving the clinic, ask for a summary of your treatment, the dates and any follow-up instructions. Keep a copy of your medical records and treatment summary for your doctor at home.

Step 8: Follow-up at home

Follow-up is part of the treatment, not an afterthought. Before you leave Japan, confirm three things in writing: who you contact if symptoms appear, how the contact will respond, and which tests should be repeated at home and how the results will be shared.

Companions affect the visa as well. The guarantor and the patient agree on whether a companion is needed, and the companion's details are written into the guarantor's guarantor letter. Under the guidance, if a companion goes missing in Japan, the patient's own visa may be cancelled, and the patient may be refused any Japanese visa in future. The guarantor must make that clear to the patient in advance.

Common mistakes to avoid

  • Starting travel before the filed plan has been confirmed for the specific treatment.
  • Assuming that a guarantor or agency can replace the treating doctor's assessment.
  • Signing a consent form that you have not read in full.
  • Booking flights without knowing how many visits the treatment requires.
  • Leaving Japan without a written plan for follow-up.

Close-up of three dark red passport booklets stacked on a light surface with a white plastic card resting diagonally on top.

Frequently asked questions

Do I need a filed plan to receive regenerative treatment in Japan?

Yes. A clinic that offers regenerative medicine must file a provision plan under the Safety Act before providing it. Without a filed plan for your specific treatment, the treatment cannot be provided lawfully.

Who arranges the visa for a medical treatment trip?

A medical stay visa needs a guarantor, which is either a registered travel agency on list A or a registered international medical coordinator on list B. The guarantor issues the guarantor letter with the receiving hospital's schedule certificate.

Can I use a short-stay visa instead of a medical stay visa?

Yes. The medical stay visa does not prevent medical travelers from applying for another short-stay visa, and the applicant may choose the visa that fits the trip.

What if my treatment needs more than one trip?

Ask the clinic for a written treatment schedule. The guarantor will attach it to the visa application, and the guarantor must track each later entry if you receive multi-entry approval.

Sources: Ministry of Foreign Affairs, Ministry of Economy, Trade and Industry and Japan Tourism Agency, 医療滞在査証に係る身元保証業務取扱概要 (effective 1 August 2026; amended text, 新旧対照表); Japan Act on the Safety of Regenerative Medicine (Act No. 85 of 2013), Arts. 2, 4 and 8, and Enforcement Regulations, Arts. 35–36 (e-Gov text); MHLW, "Regenerative Medicine, Cell Therapy and Gene Therapy" page. Checked November 2026; MHLW (or the relevant body) publications prevail.

Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.